Class 1, 2, and 3 <i>BRAF</i> -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization
Marta Schirripa(Azienda Sanitaria Locale Viterbo), Matteo Fassan(University of Padua)
Cited by 107
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Evolution of HER2-low expression from primary to recurrent breast cancer
|npj Breast Cancer|2021|226
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment
|npj Breast Cancer|2022|100